arrow
B

Birgitte Lausen

Rigshospitalet
H指数:32
被引数:3,345

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characteristics and Outcomes of Adolescents (15–18 Years) with Chronic Myelogenous Leukemia (CML) in Chronic Phase: The Experience of the International Registry of Childhood CML

慢性粒细胞白血病慢性期青少年(15–18岁)的特征与结局:国际儿童CML登记研究的经验

Cancers
IF4.4
2026-06-170
OA
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia

复发婴儿及儿童KMT2A重排急性白血病的基因组景观

2025-10-080
OAAI
Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNXI::RUNXITI

在携带RUNXI::RUNXITI的急性髓系白血病儿童中,诱导期间出现白血病相关的具有非典型免疫表型的嗜碱性粒细胞和肥大细胞,不应被解释为可测量的微小残留病。

BLOOD
IF23.1
2024-11-050
PRE
Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 protocol
2024-05-090
OAAI
Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course

小儿慢性粒细胞白血病诊断中贫血的患病率及其对病程的预后影响

2022-11-125
PRE
Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia
2022-10-012
OAAI
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol
2022-01-019
OA
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

伊马替尼一线治疗儿童和青少年慢性粒细胞白血病: 一项III期临床试验的结果

LEUKEMIA
IF13.4
2018-06-2082
PREAI
Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature

伴有t(7;12)(q36;p13) 的急性髓系白血病 (AML) 与婴儿期和19三体相关: 来自北欧儿科血液学和肿瘤学会 (nopho-aml) 的数据和文献综述

2018-04-3023
PREAI
Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents
CANCER
IF5.1
2017-05-1223
OAAI